ONESOURCE1,548.10

Onesource Specialty Pharma Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersSTARDIVISLABGLANDPFIZERPOLYMEDRAINBOWKIMSJUBLPHARMAMcap ₹17,744 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations68.0392.6426.0327.3375.8290.3428.2449.0
Other Income0.65.42.95.33.04.62.13.8
Total Income68.6398.0428.8332.5378.8295.0430.3452.8
Expenses
+ Cost of Materials Consumed12.392.991.083.4123.587.7144.5141.2
+ Purchases of Stock-in-Trade0.00.0-8.00.00.00.00.00.0
+ Changes in Inventories0.08.727.99.6-10.16.61.81.1
+ Employee Benefit Expense22.857.351.158.462.864.262.768.7
+ Finance Costs20.745.833.427.534.038.222.530.8
+ Depreciation & Amortisation19.168.868.567.869.869.671.871.7
+ Other Expenses32.890.581.587.493.0114.5127.3114.7
Total Expenses107.6363.9345.3334.1373.1380.9430.6428.2
EBITDA0.1143.2182.588.5106.517.391.9123.3
EBIT-18.974.4114.020.736.7-52.320.151.6
Profit
PBT before Exceptional Items-39.134.083.5-1.55.7-85.9-0.324.6
+ Exceptional Items0.0-100.50.0-2.90.0-7.10.0-4.3
Pretax Income-39.1-66.583.5-4.45.7-93.0-0.320.3
+ Current Tax0.06.0-10.70.20.90.60.50.3
+ Deferred Tax0.0-3.6-4.7-4.4-5.6-5.0-5.4-5.0
Tax Expense0.02.3-15.4-4.2-4.7-4.3-4.9-4.7
+ Share of Associates & JVs-0.20.00.00.00.00.00.00.0
Net Income-39.3-68.898.2-0.210.5-88.74.625.0
+ Net Income — Continuing Ops-39.1-68.898.9-0.210.5-88.74.625.0
+ Net Income — Discontinued Ops0.00.0-0.70.00.00.00.00.0
+ Other Comprehensive Income0.00.02.23.05.8-3.410.73.6
Total Comprehensive Income-39.3-68.8100.42.816.3-92.115.328.6
Net Income to Common0.00.0-88.74.60.0
Minority Interest0.0-1.90.00.00.0
Per Share
Basic EPS-18.82-6.318.61-0.020.92-7.740.402.18
Diluted EPS-18.82-6.318.59-0.020.91-7.740.402.18
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax0.00.0-0.70.00.00.00.00.0
Other Comprehensive Income — detail
+ Other Comprehensive Income2.23.05.8-3.410.73.6
+ Items NOT to be Reclassified to P&L0.03.05.8-5.5-1.11.2
+ Tax on Items NOT to be Reclassified-2.20.00.00.00.00.0
+ Items to be Reclassified to P&L2.111.82.4
Comprehensive Income — Owners of Parent0.00.0-92.110.70.0
Per Share — as-filed variants
Basic EPS — Continuing Operations-9.41-6.318.61-0.020.92-7.740.402.18
Diluted EPS — Continuing Operations-9.41-6.318.59-0.020.91-7.740.402.18
Basic EPS — Discontinued Operations-9.410.000.000.000.000.000.000.00
Diluted EPS — Discontinued Operations-9.410.000.000.000.000.000.000.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit55.7291.0315.0234.4262.3196.0282.0306.7
Gross Margin %81.8974.1473.9671.6169.8067.5065.8468.30
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)-39.134.083.5-1.55.7-85.9-0.324.6
− Exceptional Items (reconciliation)0.0-100.50.0-2.90.0-7.10.0-4.3
Net Income Adj (tax-effected)-39.331.798.21.010.5-81.94.629.3
EPS Adj-18.822.908.610.100.92-7.150.402.56
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.001.001.001.001.00
Filed Debt Equity0.020.000.000.00
Filed Dscr0.000.000.02
Filed Iscr-0.010.020.04
Paid Up Equity Capital4.211.411.411.411.511.511.511.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.